United States Renal Denervation (RDN) Therapy Market was valued at USD 0.65 Billion in 2022 and is projected to reach USD 1.7 Billion by 2030, growing at a CAGR of 12.7% from 2024 to 2030.
The US Renal Denervation (RDN) Therapy Market has witnessed significant advancements in recent years, driven by growing demands from healthcare providers and industries addressing hypertension and other kidney-related diseases. Renal denervation, a non-invasive procedure aimed at treating high blood pressure by targeting the renal nerves, is gaining momentum as an effective solution to manage resistant hypertension, a condition that often doesn’t respond to traditional medications.
As the US healthcare system grapples with the rising burden of hypertension, the market for RDN therapy continues to expand. The primary drivers of growth in the market are the increasing prevalence of hypertension, advancements in RDN technologies, and the rising awareness about the potential of this therapy. The need for effective solutions to address resistant hypertension is driving demand for RDN procedures, which have proven to be highly effective in clinical trials and real-world applications.
Industries involved in the Renal Denervation (RDN) Therapy Market are primarily focused on developing innovative devices and therapies that can provide long-term relief to patients. These industries require cutting-edge technology, such as catheter-based systems, that allow for precise delivery of energy to the renal nerves. The evolution of minimally invasive techniques has been instrumental in making RDN procedures more accessible and less risky, further accelerating market growth.
Additionally, as patients and physicians continue to seek out alternatives to traditional drug therapies, the requirement for RDN therapy is increasing, particularly in areas with high rates of hypertension. With the continuous push toward patient-centric care and personalized treatments, RDN technology fits perfectly within the broader trend of offering tailored healthcare solutions. As more hospitals and clinics invest in these advanced technologies, the market for RDN therapy is expected to experience significant growth in the coming years.
RDN therapy holds immense potential to change the way hypertension is treated. Its role in tackling high blood pressure, especially in resistant cases, positions it as a cornerstone of future cardiovascular care. The US Renal Denervation (RDN) Therapy Market is poised for substantial growth as industries and healthcare providers strive to meet the increasing demand for innovative treatments.
Get an In-Depth Research Analysis of the US Renal Denervation (RDN) Therapy Market Size And Forecast [2025-2032]
Â
Medtronic (Covidien)
ReCor
Johnson & Johnson
Boston Scientific
Shanghai Golden Leaf Med Tec Co.
Ltd
Bio-Heart
SyMap Medical
Venus Medtech
Shanghai Microport Ep Medtech Co.
Ltd.
Cryofocus Medtech
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Renal Denervation (RDN) Therapy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Renal Denervation (RDN) Therapy Market
Radiofrequency-based RDN Devices
Cryoablation Devices
Ultrasound-based RDN Devices
Multielectrode RDN Systems
Catheter-based RDN
Surgical RDN
Endovascular RDN
Robotic-assisted RDN
Uncontrolled Hypertension
Resistant Hypertension
Secondary Hypertension
Diabetic Nephropathy
Hospitals
Outpatient Surgery Centers
Specialized Clinics
Research Institutions
Catheter Technologies
Data Integration Technologies
Imaging Technologies
Navigation Technologies
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Renal Denervation (RDN) Therapy Market Research Analysis
1. Introduction of the US Renal Denervation (RDN) Therapy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Renal Denervation (RDN) Therapy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Renal Denervation (RDN) Therapy Market, By Type
6. US Renal Denervation (RDN) Therapy Market, By Application
7. US Renal Denervation (RDN) Therapy Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Renal Denervation (RDN) Therapy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/